Bausch & Lomb director granted 1,415 share units
Bausch & Lomb Corp director Steven H. Collis received a grant of restricted share units in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Bausch & Lomb Corp director Steven H. Collis received a grant of restricted share units in the company. On this award date, he acquired 1,415 restricted share units, each representing a contingent right to receive one common share of Bausch & Lomb. Following this award, his directly held common share-equivalent position reported in this filing is 26,161 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares, No Par Value | 1,415 | $15.90 | $22K |
Footnotes (1)
- F1. Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation.
Key Figures
Key Terms
contingent right financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did BLCO director Steven H. Collis report?
What type of security was granted to Steven H. Collis by Bausch & Lomb (BLCO)?
Was Steven H. Collis buying or selling BLCO stock in this filing?
Does this BLCO Form 4 indicate any derivative exercises or option trades?
AI-generated analysis. How Rhea-AI works. Not financial advice.